MedTrace Logo

Measuring Sleep Disturbance Among Cancer Patients

NCT00505544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 459

Last updated 2022-07-13

No results posted yet for this study

Summary

Objectives:

Primary Objectives:

1. To establish concurrent criterion-related validity of the Brief Sleep Disturbance Scale (BSDS) by correlating the scale with the Pittsburgh Sleep Quality Index.
2. To evaluate the construct validity of the BSDS through exploratory factor analysis.
3. To examine possible predictors of sleep disturbance.
4. To evaluate the reliability of the BSDS using Cronbach's coefficient alpha and test-retest reliability.
5. To evaluate the sensitivity of the BSDS by administering it to the same group of patients (n = 60) prior to treatment with a regimen associated with sleep disturbance, during 4 weeks of treatment, and upon completion of treatment.
6. To evaluate the psychometric properties of the BSDS in a sample of community dwelling adults.

Secondary Objective:

1\. To obtain pilot data from a small sample of patients who will wear an actigraph for one week.

Conditions

Interventions

BEHAVIORAL

Questionnaire

Questionnaires that ask about your sleep, symptoms, and mood.

DEVICE

Actigraph

Wear actigraph to collect information on activity levels and sleep patterns for one week.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Xin S. Wang, MD,MPH · M.D. Anderson Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2022-07-11
Completion
2022-07-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00505544 on ClinicalTrials.gov